Association of immune function with bone mineral density and biochemical markers of bone turnover in patients with anklylosing spondylitis

International Journal of Clinical Practice

Volumn 57, Issue 8, 2003, Pages 681-685

  Yilmaz, N ^a   Pence, Sadrettin ^a   Kepekci Y ^a   Geyikli, I ^a   Ozaslan J ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; DEOXYPYRIDINOLINE; LYMPHOCYTE SURFACE MARKER; LYMPHOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCALCIN; PYRIDINOLINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CELL INTERACTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR NECK; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE; MALE; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; SPONDYLITIS, ANKYLOSING;

EID: 0242575110     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lauries S, Geppert T, Meek K et al. Immune and inflammatory responses Textbook of rheumatology. Philadephia: WB Saunders, 1997; 95-128.
2. Dana JMB, Tsuchiya N, Yamaguchi A et al. Immunologic mechanism in common rheumatologic diseases. Clin Ortho Rel Res 1996; 326: 43-54.
3. Abbas KA, Linethman HA, Pober SJ. Cellular and molecular immunology. Philadelphia: WB Saunders, 1997; 37-249.
4. Toussirot E, Wendling D. Osteoporosis in ankylosing spondylitis. Press Med 1996; 25: 70-74.
5. Tapia-Serrano R, Jimenez-Balderas FJ, Murrieta S et al. Testicular function in active ankylosing spondylitis: therapeutic response to human chorionic gonadotropin. J Rheumatol 1991; 18: 841-848.
6. Bronson WD, Walker SE, Hillman LS et al. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 1998; 25: 929-935.
7. Murray GC, Persellin RH. Cervical fracture complicating ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med 1981; 70: 1033-1041.
8. Handling JR, McCall IW, Park WM, Jones BF. Fracture of the cervical spine in ankylosing spondylitis. Br J Radiol 1985; 58: 3-7.
9. Hunter T, Dubo H. Spinal fractures complicating ankylosing spondylitis. Ann Intern Med 1978; 88: 546-549.
10. Yilmaz N, Bayram M, Erbagci AB, Kilinçer MS. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Clin Chem Lab Med 1999; 37(2): 137-143.
11. Westerhuis LWJJM, Delaere KPJ. Diagnostic value of some biochemical bone markers for the detection bone metastases in prostate cancer. Eur J Clin Chem Clin Biochem 1997; 35: 89-94.
12. Yilmaz N, Özaslan J. Biochemical bone turnover markers in patients with ankylosing spondilitis. Clin Rheumatol 2000; 19: 92-98.
13. Suzuki M, Takahashi S, Miyamoto S et al. The effects of menopausal status and diseases activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. Br J Rheumatol 1998; 37: 653-658.
14. Ohishi T, Takahashi M, Kawana K et al. Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects. Clin Invest Med 1993; 16: 319-325.
15. Sinigaglia L, Varenna M, Binelli L et al. Urinary and synovial pyridinium cross-link concentrations in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995; 54: 114-147.
16. Schneider U, Breusch SJ, Termath S et al. Increased urinary crosslink levels in aseptic loosening of total hip arthroplasty. J Arthro 1998; 13: 687-692.
17. Shaarawy M, El-Dawakhly AS, Mosaad M, El-Sadek MM. Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women. Clin Chem Lab Med 1999; 37: 433-438.
18. Gough A, Sambrook P, Devlin J et al. Osteoclastic activation is the principal mechanism leading to secondary in rheumatoid arthritis. J Rheumatol 1998; 25: 1282-1289.
19. Garnero P, Delmas PD. Assessment of the serum levels of the bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993; 77: 1046-1053.
20. Moll JMH, Wright V. New York clinical criteria for ankylosing spondylitis. Ann Rheum Dis 1973; 32: 354-363.
21. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Diseases Activity Index. J Rheumatol 1994; 21: 2286-2291.
22. JR BG, Ardakani S, Evans BJ et al. Monoclonal antibody assay for the free urinary pyridium cross-links. Clin Chem 1996; 42: 1168-1175.
23. Aloia JF, Mikhail M, Pagan CD et al. Biochemical and hormonal variables in black and white women matched for age and weight. J Lab Clin Med 198; 132: 383-389.
24. Giltay EJ, Popp-Snijders C, van Schaardenburg D et al. Serum testosterone levels are not elevated in parents with ankylosing spondylitis. J Rheumatol 1998; 25: 2389-2394.
25. Donelly S, Doyle DV, Denton A et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994; 53: 117-121.
26. Sivri A, Kilinc S, Gökce Kutsal Y, Ariyurek M. Bone mineral density in ankylosing spondylitis. Clin Rheumatol 1996; 15: 51-54.
27. Lanyi E, Gömör B, Ratko I. Determination of diminished mineral density in ankylosing spondylitis. Orv Hetil 1997; 138: 2227-2229.
28. Franck H, Keck E. Serum osteocalcin and vitamin D metabolites patients with ankylosing spondylitis. Ann Rheum Dis 1993; 52: 343-346.
29. Marhoffer W, Stracke H, Masoud I et al. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis 1995; 57: 556-559.
30. Braun J, Bollow M, Neure L et al. Use of immunohistologic and in-situ hybridisation techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondilitis. Arthitis Rheum 1995; 38: 499-505.
31. Wang JY, Yeh HY, Tu ST, Chen AC. Immunological study in three families of juvenile ankylosing spondilitis. Acta Pediatr Sin 1992; 33: 191-199.
32. Hermann E, Ackermann B, Duchmann R et al. Synovial fluid MHC-unrestricted gamma delta-T lymphocyte contribute to antibacterial and antiself cytotoxicity in spondyloarthropaties. Clin Exp Rheumatol 1995; 13: 187-191.
33. Macey MG, Wilton JM, Carbon R et al. Leukocyte activation and function associated antigens in inflammatory disease. Agents Actions 1993; 38: C39-C40.
34. Yakota A, Murata N, Saiki O et al. High avidity state of leukocyte function associated antigen-I on rheumatoid synovial fluid T lymphocytes. J Immunol 1995; 155: 4118-4124.
35. Montenegro V, Chiamolera M, Launay P et al. Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis. J Rheumatol 2000; 27: 411-417.
36. Marie P, Debias F, Marie CS et al. New factors controlling bone remodelling joint bone spine. Joint Bone Spine 2000; 67: 150-156.